Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Scotia schizophrenia project develops rapidly

Nov. 8, 1996

5-HT1A receptor agonists from Sankyo

Nov. 8, 1996

Yoshitomi describes compounds for anxiety and epilepsy

Nov. 8, 1996

Migraine-related gene discovered by Dutch researchers

Nov. 8, 1996

Focus on present and future migraine therapy

Nov. 8, 1996

Menarini receives U.S. patent coverage for single-isomer analgesic

Nov. 8, 1996

Lilly reports 5-HT1F agonists for migraine

Nov. 8, 1996

Novel tachykinin antagonists from Glaxo Wellcome

Nov. 8, 1996

NK1 antagonists described by Merck & Co.

Nov. 8, 1996

NPS Pharm. selects NMDA antagonist for further testing

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...